Guidelines for the diagnosis of uncomplicated cirrhosis.

Fontaine H, Petitprez K, Roudot-Thoraval F, Trinchet JC, Association francaise pour l'etude du foie …

MeSH — NLM indexing Biopsy / economics Child Elasticity France Hematologic Tests / economics Hepatitis C / diagnosis Humans Liver Cirrhosis / classification Liver Cirrhosis / diagnosis Liver Cirrhosis / diagnostic imaging Liver Cirrhosis / etiology Liver Function Tests / economics Ultrasonography

Staff actions

Download PDF

Files are for authorised use within BioPredictive partner channels only.

Fibrotest Actitest Guideline Independent Group France

Authors (11)

Fontaine H — Unité d'Hépatologie Médicale, Hôpital Cochin, Paris, France.
Petitprez K
Roudot-Thoraval F
Trinchet JC
Association francaise pour l'etude du foie

Fontaine H — Unité d'Hépatologie Médicale, Hôpital Cochin, Paris, France.
Petitprez K
Roudot-Thoraval F
Trinchet JC
Association francaise pour l'etude du foie
Club de reflexion des cabinets et groupes d'hepato-gastro-enterologue
College national des generalistes enseignants
Groupe francophone d'hepatologie gastro-enterologie et nutrition pediatriques
Societe francaise de biologie clinique
Societe francaise de radiologie
Societe nationale francaise de gastro-enterologie

Citation

Fontaine H, Petitprez K, Roudot-Thoraval F, Trinchet JC, Association francaise pour l'etude du foie, Club de reflexion des cabinets et groupes d'hepato-gastro-enterologue, et al. Guidelines for the diagnosis of uncomplicated cirrhosis. Gastroenterol Clin Biol. 2007;31(5):504-9. PMID:17541342.

Identifiers

PMID: 17541342

Tests

Liver diseases

Liver injuries

Subjects

Region

Guidelines for the diagnosis of uncomplicated cirrhosis.

More on the same topic

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Toward non-invasive assessment strategies in autoimmune hepatitis.

Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants.

Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts.